Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$268,954
+$10,093 QoQ
Shares Held
1,059
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#4,261
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Oliver Luxxe Assets LLC holds $24,335,082 across 7 Drug Manufacturers - General names. JNJ ranks #5 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
45,272 | $8,584,476 | |
| 2 | ABBV |
AbbVie Inc.
|
31,485 | $7,922,885 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
52,852 | $6,677,321 | |
| 4 | PFE |
Pfizer Inc
|
18,762 | $451,788 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
1,059 | $268,954 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,681 | $216,008 | |
| 7 | AMGN |
Amgen Inc
|
590 | $213,650 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $268,954 | 1,059 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $258,861 | 1,059 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $323,669 | 1,564 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $367,502 | 1,982 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $273,269 | 1,789 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $315,759 | 1,904 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $253,518 | 1,753 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $300,135 | 1,852 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $284,427 | 1,946 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $301,351 | 1,905 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $299,216 | 1,909 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $314,926 | 2,022 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $333,357 | 2,014 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $328,290 | 2,118 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $4,061,006 | 22,989 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $3,698,470 | 22,640 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,784,599 | 15,687 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,722,607 | 15,362 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $409,028 | 2,391 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $386,146 | 2,391 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $526,344 | 3,195 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $483,846 | 2,944 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $463,169 | 2,943 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $446,937 | 3,002 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $422,171 | 3,002 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $393,652 | 3,002 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||